CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. - Wikidata - wikimedia - TriplyDB

CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

http://www.wikidata.org/entity/Q36691117

about

Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines Current perspectives on the immunopathogenesis of systemic sclerosis MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induced fibrosis Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.Emerging targets for the treatment of scleroderma.Immunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questions Polymorphisms in SELE gene and risk of coal workers' pneumoconiosis in Chinese: a case-control study.Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.B cells in cardiac transplants: from clinical questions to experimental models Molecular and cellular mechanisms of pulmonary fibrosis.A genetic approach to the prediction of drug side effects: bleomycin induces concordant phenotypes in mice of the collaborative cross.Potential effector and immunoregulatory functions of mast cells in mucosal immunity.Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.Fibrocytes: emerging effector cells in chronic inflammation Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.CD19 and CD32b differentially regulate human B cell responsiveness.TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis.Semaphorin7A: branching beyond axonal guidance and into immunity.Scleroderma therapy: clinical overview of current trends and future perspective.Role of toll-like receptors in systemic sclerosis.Animal models of scleroderma: current state and recent development.Innate immunity in systemic sclerosis pathogenesis.Molecular and cellular basis of scleroderma.Abnormal B lymphocyte activation and function in systemic sclerosis.The role of the acquired immune response in systemic sclerosis.Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.Interstitial lung disease in systemic sclerosis: current and future treatment.Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis.

P2860

Q24310749-F36C57F2-5272-4FF5-9294-DF456640F50F Q26741264-85B06507-7D8E-42A5-8F3C-C7ED5C478E4A Q26781257-0E26ECB6-2318-4C89-9235-B4EC3889BF69 Q27022117-0F87F7AC-2015-48BD-AC0B-8DCDBACD2D4C Q27301282-E6A86A5F-40A7-423C-B8D7-F9A9026FEDE4 Q28072685-96CDE10C-5A82-4923-B43D-442F5CE481BA Q28073706-39056D6F-792C-4245-A1C7-49DA9F69328F Q30525106-EF9C6A8E-D2DD-4F5B-8583-AE287CBD1F75 Q33577617-CDCDE684-CFBC-4B75-8268-8625AEBC8287 Q33653276-62E2EA6C-954B-4BC1-A96F-C38F89382B3B Q33923359-F24EBCEE-C05E-47F6-8A20-63018EC46BF0 Q34270856-ED52904F-6DB9-47F8-8E57-2317338C9FEA Q34289043-64CA1759-F78F-4BCA-AE3C-696BCAEABC93 Q34996990-D33042B3-8D49-465D-9685-B8DC06EECB12 Q35127552-35C27934-585D-4F6B-88A4-9C1612B86920 Q35780746-AF61803D-056D-4B60-87D1-2BDF7224FC00 Q35840324-7EFB67E7-5C21-4AD1-91AA-F0569218B52A Q36237168-655F3B1F-A97C-4293-BE27-350847C2E209 Q36441496-8C985FEA-9507-4571-B811-6EF760EEB408 Q36539857-1B17A0E6-0326-4595-81D3-16CDC37E2596 Q36605083-A8FDA33B-8618-4CED-9579-22BF924AFB4C Q36615191-760C9F18-ECE3-4804-85F7-3298D0C5A596 Q36690680-2CD50E3B-0C89-4960-939C-A63B70B855D8 Q37069130-9C8C9BF7-723B-4FC5-AED6-7BA2590BC006 Q37571579-BA038301-D1AC-4177-9013-8876110CA316 Q37595691-9CB3365B-EA34-47D3-AC84-617649CF3A16 Q37627201-52408587-E6F4-4EB9-B4B6-B089EBAB17F3 Q37665093-AD4ACB65-1B7F-4982-A0E4-192E073ED406 Q38046467-6B245AE4-274B-4723-9858-3F8D67F4911A Q38132298-A3439D14-09BB-4462-9B88-BC86257D1A0E Q38154834-5FB15019-ECE7-4F03-8818-A952BB2D46D4 Q38161937-D8ECAF7F-9EBF-4F7A-9446-8D43236DE9D3 Q38230276-6C55FD92-1285-4E33-AD1B-B7E9496623F3 Q38352418-03D283FE-EDBC-4C9D-9B37-BD5221616094 Q38543690-292D7B26-F8A7-4E2E-AF88-5375903FB208 Q38681751-739FA6A6-F669-46DE-91AF-0D3C47261F8F Q38701988-8114124D-4FCA-40A8-B441-8A0921BA8695 Q38773637-A12ECC69-22AA-485F-86FB-58A2A469D7FC Q38885566-5EF2631B-05CD-4A67-8DF5-EE79F1EF0A69 Q40236906-9FBC2D7F-E875-4759-AF34-3D00BC30C90E

P2860

CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

http://www.wikidata.org/entity/Q36691117

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

CD19 regulates skin and lung f ...... bleomycin-induced scleroderma.

@ast

CD19 regulates skin and lung f ...... bleomycin-induced scleroderma.

@en

type

label

CD19 regulates skin and lung f ...... bleomycin-induced scleroderma.

@ast

CD19 regulates skin and lung f ...... bleomycin-induced scleroderma.

@en

prefLabel

CD19 regulates skin and lung f ...... bleomycin-induced scleroderma.

@ast

CD19 regulates skin and lung f ...... bleomycin-induced scleroderma.

@en

P1433

Q36691117-EEFDEBC1-0507-4172-AC55-685B56C98001

P1476

Q36691117-B2C008E4-3743-4884-A1E4-286DF0A11847

P2093

Q36691117-18AE5E25-59B2-475D-A492-D05C36E264BB

Q36691117-195FC50E-EEB2-47BB-9BDC-EB27ED097DE5

Q36691117-7766828C-13B9-4343-ADBF-ADF7EF8A8C01

Q36691117-8AE09710-4885-46D6-AC63-017AEF82017A

Q36691117-97E0F534-4372-4D6C-A439-9887FDB875C8

Q36691117-AF8B8CAE-555D-404A-9581-99A268046430

Q36691117-B45ADDDD-493F-41BF-9A02-3956E02FD0FD

Q36691117-C8731D90-7BB2-4A9C-9F3C-923648729C47

Q36691117-CC54748A-A843-456F-AA90-FAB0DAC5071D

Q36691117-CE955F07-5337-4606-8458-A3ACFACF0929

P2860

Q36691117-01CC429D-5AAE-41B7-ACFE-B5292BC5F130

Q36691117-062C9651-32A2-45F5-B67F-2EE759ADA6F7

Q36691117-09907FE7-A22E-43D1-949E-8E8AADB930DC

Q36691117-0AEBF56B-D116-4753-93B7-8F9936809A8B

Q36691117-13174204-762F-4D58-894D-DCEE3DDED80D

Q36691117-21B02C1F-F8CC-42C6-8D82-B6123D59B6DD

Q36691117-2D2D3BC8-F16A-4F7C-885E-1DCE2A83EFD3

Q36691117-2DBE1ED7-90FC-4668-A942-75DEC87C99CE

Q36691117-316F91B9-8B16-4FDF-A615-73C0E07525EA

Q36691117-32809A26-AF5D-44C7-86CF-361C59E164AC

P304

Q36691117-A6FD78C0-4B12-47AB-B23D-DE0C985D07A7

P31

Q36691117-C25BB32F-06CF-4EA3-AF22-CA8B27E92753

P356

Q36691117-686470E1-3EF4-417F-BA7C-B1219DBD649A

P407

Q36691117-2F56F033-7113-41C7-A59F-27F6384F9E82

P433

Q36691117-4A473440-CB9D-43A1-87A4-0253AB8AA1D7

P478

Q36691117-09391292-CE42-45A1-AFE6-524305E063BC

P50

Q36691117-2DAC6B34-0AF2-4ABC-8425-6C1BF8BACB3D

Q36691117-5F1014AD-EDD6-409D-BC27-9ACC11B3E24B

P577

Q36691117-69B2EF8D-1358-4A8F-981A-F2DAD4C3243D

P5875

Q36691117-F84BC516-16D2-4CD8-816A-AF3EDAA37EC1

P698

Q36691117-3EE7A005-F8F7-4D88-A972-E8A18DA51DC7

P921

Q36691117-2D4CA4C4-D04D-4D09-8BF8-D9E189BABC20

Q36691117-EB7969C0-7A86-4B55-9E70-8C7E9DA140A7

P932

Q36691117-93BAAEEF-DE8E-464D-B326-7419A7210D26

P356

AJPATH.2008.071049

P1433

The American Journal of Pathology

P1476

CD19 regulates skin and lung f ...... bleomycin-induced scleroderma

@en

P2093

Ayumi Yoshizaki

http://www.w3.org/2001/XMLSchema#string

Eiji Muroi

http://www.w3.org/2001/XMLSchema#string

Fumihide Ogawa

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Shimizu

http://www.w3.org/2001/XMLSchema#string

Manabu Fujimoto

http://www.w3.org/2001/XMLSchema#string

Motoi Takenaka

http://www.w3.org/2001/XMLSchema#string

Shinichi Sato

http://www.w3.org/2001/XMLSchema#string

Thomas F Tedder

http://www.w3.org/2001/XMLSchema#string

Toshihide Hara

http://www.w3.org/2001/XMLSchema#string

Yohei Iwata

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells

Age-associated alterations in CXCL1 chemokine expression by murine B cells

Innate immune recognition

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease.

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts.

Hyaluronan catabolism: a new metabolic pathway.

Regulation of lung injury and repair by Toll-like receptors and hyaluronan.

P304

1650-1663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2008.071049

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

Kazuhiro Komura

Minoru Hasegawa

P577

2008-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5383263

http://www.w3.org/2001/XMLSchema#string

P698

18467694

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

Toll-like receptor

P932

2408424

http://www.w3.org/2001/XMLSchema#string